2-((1H-Azol-1-yl)methyl)-N-arylbenzamides: Novel dual inhibitors of VEGFR-1/2 kinases
Novel potent derivatives of (azol-1-yl)methyl-N-arylbenzamides with improved solubility (>3 mM) are described as ATP-competitive inhibitors of vascular endothelial growth factor receptor 2 (VEGFR-2). Many compounds display VEGFR-2 inhibitory activity reac
Kiselyov, Alexander S.,Semenova, Marina,Semenov, Victor V.,Piatnitski, Evgueni
p. 1726 - 1730
(2007/10/03)
More Articles about upstream products of 879213-62-4